APA (7th ed.) Citation

A, W., P, G., A, M., B, M., ME, N., ML, P., . . . MS, M. (2026). Aficamten in Obstructive Hypertrophic Cardiomyopathy: A Multidomain, Patient-Level Analysis of the MAPLE-HCM Trial. Journal of the American College of Cardiology, 87(8), 1029. https://doi.org/10.1016/j.jacc.2025.10.057

Chicago Style (17th ed.) Citation

A, Wang, et al. "Aficamten in Obstructive Hypertrophic Cardiomyopathy: A Multidomain, Patient-Level Analysis of the MAPLE-HCM Trial." Journal of the American College of Cardiology 87, no. 8 (2026): 1029. https://doi.org/10.1016/j.jacc.2025.10.057.

MLA (9th ed.) Citation

A, Wang, et al. "Aficamten in Obstructive Hypertrophic Cardiomyopathy: A Multidomain, Patient-Level Analysis of the MAPLE-HCM Trial." Journal of the American College of Cardiology, vol. 87, no. 8, 2026, p. 1029, https://doi.org/10.1016/j.jacc.2025.10.057.